| Reduced Risk Status: |
|
| IPM Compatibility: |
PER REQUESTER: VERY GOOD FIT; THE MODE OF ACTION IS DIFFERENT THAN OTHER REGISTERED FUNGICIDES:08/22
|
| Reasons for need: |
STEMPHYLIUM VESICARIUM; CURRENT FUNGICIDES INCLUDE THE PROTECTANTS AND THE STROBILURINS WHICH ARE NOT ADEQUATE AND DO NOT PROVIDE LONG-LASTING PROTECTION;
|
| Requesting State(s): |
MI:Hausbeck, M* ;
|
| PCR Use Pattern: |
MIRAVIS PRIME SC, DOSAGE 11.4 FL OZ/A, FOLIAR APPLICATION, 5 APPLICATIONS, RTI 14 DAYS, PHI 7 MONTHS; APPLY AS A FOLIAR SPRAY
|
| EPA Default Residue Trials: |
2 5-2 10-3 11-2
|
| IR-4 Residue Trial Plan: |
2 5-2 10-2 11
|
| Residue Protocol Use Pattern: |
USE THE MIRAVIS PRIME PRODUCT (1.25 LB AI OF PYDIFLUMETOFEN AND 2.09 LB AI OF FLUDIOXONIL ACTIVE INGREDIENTS/GAL OF PRODUCT); MAKE 2 FOLIAR BROADCAST APPLIC OF 396 ML PRODUCT/A , IN 20-50 GPA; 14-DAY INTERVAL, TO THE ASPARAGUS FERNS DURING THE GROWING SEASON, WITH LAST APPLIC A MINIMUM OF 7 MONTHS PRIOR TO HARVEST; EACH APPLIC SHALL INCLUDE A LABEL RATE OF AN ADJUVANT
|
| Efficacy/Crop Safety (E/CS) Data Required: |
Sygenta advised no add'l efficacy trials are needed:01/24/sb
|
| E/CS Research Comments: |
SEE PR#13493 FOR PROTOCOL/DETAILS OF TESTING MERIVON XEMIUM (FLUXAPYROXAD + PYRACLOSTROBIN) AND MIRAVIS PRIME (FLUDIOXONIL + PYDIFLUMETOFEN) FOR PURPLE SPOT CONTROL; Syngenta does not need anything beyond the 2 IR-4 efficacy trials already provided to them:01/24/sb
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
Green 02/23
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
THE PERFORMANCE PROTOCOL FOR THIS PR# IS ASSOCIATED WITH PR# 13493 RESULTS FROM TEH PROTOCOL WILL BE POSTED TO BOTH PR#'S: 03/23, JPB;
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|